Biosynth
Ralf Wehen has extensive experience in financial leadership, serving as Chief Financial Officer at both Biosynth and Discovery Life Sciences. In addition to these roles, Ralf has held significant positions such as Group CFO and Managing Director at ORGENTEC Diagnostika GmbH and pepcom GmbH. Ralf also contributes as an Advisory Board Member for Schaidt Innovations GmbH & Co KG, demonstrating a commitment to guiding organizations in strategic financial management.
This person is not in any teams
This person is not in any offices
Biosynth
2 followers
Biosynth specializes in antibody packages and custom peptide synthesis services for small and large scale industries